Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia (Q34040090)

30 July 2017

1 reference

title

Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia (English)

1 reference

hyperalphalipoproteinemia

30 July 2017

1 reference

1 reference

1 reference

Yamashita S

1

1 reference

30 July 2017

Maruyama T

2

1 reference

30 July 2017

Hirano K

3

1 reference

30 July 2017

Sakai N

4

1 reference

30 July 2017

Nakajima N

5

1 reference

30 July 2017

Matsuzawa Y

6

1 reference

30 July 2017

language of work or name

1 reference

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

152

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

271-285

1 reference

Plasma lipid transfer proteins

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Reverse cholesterol transport--a review of the process and its clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Pre-beta HDL: structure and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Lipoproteins in familial hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

A familial hyperalphalipoproteinemia with low uptake of high density lipoproteins into peripheral lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

G-->A substitution at position -75 of the apolipoprotein A-I gene promoter. Evidence against a direct effect on HDL cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Low-density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low-density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

A case of hyperalphalipoproteinemia associated with albumin complexing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Protein composition determines the anti-atherogenic properties of HDL in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Transgenic rabbit models for the study of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Organization of the human cholesteryl ester transfer protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Isolation, characterization, and assay of plasma lipid transfer proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Very High Density Lipoproteins Induced by Plasma Cholesteryl Ester Transfer Protein (CETP) Have a Potent Antiatherogenic Functiona

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900574-8

10.1016/S0021-9150(00)00574-8

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference